|
US2020061207A1
|
|
Method of delivering genes and drugs to a posterior segment of an eye
|
|
US10179146B1
|
|
Compositions and methods for mitigating drug resistant bacteria
|
|
US2017106019A1
|
|
Compositions and methods for mitigating drug resistant bacteria
|
|
US9556236B1
|
|
Compositions and methods for treating respiratory syncytial virus infection
|
|
US9091640B1
|
|
Chitosan-graphene biosensors and methods for their use
|
|
US2012289420A1
|
|
Microrna biomarkers for airway diseases
|
|
US2014004520A1
|
|
Materials and methods for profiling microRNAs
|
|
WO2011103502A2
|
|
Materials and methods for profiling micrornas
|
|
US2012093781A1
|
|
Human mast cell line and uses thereof
|
|
US2010260725A1
|
|
Materials and Methods for Treating Allergic and Inflammatory Conditions
|
|
US2010286249A1
|
|
Micro-RNAs modulating immunity and inflammation
|
|
US2008214494A1
|
|
Method of drug delivery by carbon nanotube-chitosan nanocomplexes
|
|
US2008249057A1
|
|
Protein kinase C as a target for the treatment of respiratory syncytial virus
|
|
US2008214437A1
|
|
Methods and compositions for reducing activity of the atrial natriuretic peptide receptor and for treatment of diseases
|
|
US8467868B1
|
|
Method of transdermal drug delivery
|
|
US2005266093A1
|
|
Nanogene therapy for cell proliferation disorders
|
|
US8592368B2
|
|
JAK/STAT inhibitors and MAPK/ERK inhibitors for RSV infection
|
|
US2007116767A1
|
|
Chitosan-microparticles for ifn gene delivery
|
|
CA2068694A1
|
|
Determination of dna sequences of a novel group of major grass pollen allergens and the synthesis of their corresponding recombinant proteins
|
|
CA2066801A1
|
|
Determination of dna sequences of a novel group of major grass pollen allergens and the synthesis of their correspsonding recombinant proteins
|
